nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—peripheral nervous system neoplasm—brain cancer	0.562	1	CtDrD
Tretinoin—CYP2C9—brain cancer	0.22	1	CbGaD
Tretinoin—CYP3A4—Temozolomide—brain cancer	0.00709	0.324	CbGbCtD
Tretinoin—CYP3A4—Lomustine—brain cancer	0.00602	0.275	CbGbCtD
Tretinoin—CYP3A5—Etoposide—brain cancer	0.00373	0.171	CbGbCtD
Tretinoin—CYP2C8—Etoposide—brain cancer	0.00359	0.164	CbGbCtD
Tretinoin—CRABP2—pineal body—brain cancer	0.00236	0.0553	CbGeAlD
Tretinoin—RXRA—ganglion—brain cancer	0.00169	0.0395	CbGeAlD
Tretinoin—CYP3A4—Etoposide—brain cancer	0.00146	0.0665	CbGbCtD
Tretinoin—CRABP1—hindbrain—brain cancer	0.00142	0.0333	CbGeAlD
Tretinoin—ALDH1A1—hindbrain—brain cancer	0.00107	0.0251	CbGeAlD
Tretinoin—ALDH1A1—Podofilox—Etoposide—brain cancer	0.00107	0.5	CbGdCrCtD
Tretinoin—ALDH1A1—Teniposide—Etoposide—brain cancer	0.00107	0.5	CbGdCrCtD
Tretinoin—CRABP1—brainstem—brain cancer	0.000814	0.0191	CbGeAlD
Tretinoin—RARRES1—pituitary gland—brain cancer	0.000795	0.0186	CbGeAlD
Tretinoin—NR0B1—gonad—brain cancer	0.000701	0.0164	CbGeAlD
Tretinoin—NR0B1—pituitary gland—brain cancer	0.000684	0.016	CbGeAlD
Tretinoin—RXRA—telencephalon—brain cancer	0.000651	0.0152	CbGeAlD
Tretinoin—ALDH1A2—gonad—brain cancer	0.000625	0.0146	CbGeAlD
Tretinoin—ALDH1A1—brainstem—brain cancer	0.000613	0.0144	CbGeAlD
Tretinoin—ALDH1A2—pituitary gland—brain cancer	0.00061	0.0143	CbGeAlD
Tretinoin—CRABP1—gonad—brain cancer	0.000603	0.0141	CbGeAlD
Tretinoin—CRABP1—pituitary gland—brain cancer	0.000588	0.0138	CbGeAlD
Tretinoin—CRABP1—medulla oblongata—brain cancer	0.000568	0.0133	CbGeAlD
Tretinoin—CRABP2—gonad—brain cancer	0.000545	0.0128	CbGeAlD
Tretinoin—ALDH1A1—telencephalon—brain cancer	0.000544	0.0128	CbGeAlD
Tretinoin—RXRB—telencephalon—brain cancer	0.000537	0.0126	CbGeAlD
Tretinoin—CRABP2—pituitary gland—brain cancer	0.000532	0.0125	CbGeAlD
Tretinoin—NR0B1—endocrine gland—brain cancer	0.00053	0.0124	CbGeAlD
Tretinoin—CRABP1—midbrain—brain cancer	0.000519	0.0122	CbGeAlD
Tretinoin—CRABP2—medulla oblongata—brain cancer	0.000513	0.012	CbGeAlD
Tretinoin—CRABP1—spinal cord—brain cancer	0.000506	0.0119	CbGeAlD
Tretinoin—ALDH1A2—endocrine gland—brain cancer	0.000472	0.0111	CbGeAlD
Tretinoin—ALDH1A2—head—brain cancer	0.000466	0.0109	CbGeAlD
Tretinoin—RXRG—pituitary gland—brain cancer	0.000465	0.0109	CbGeAlD
Tretinoin—CRABP2—spinal cord—brain cancer	0.000458	0.0107	CbGeAlD
Tretinoin—CRABP1—endocrine gland—brain cancer	0.000456	0.0107	CbGeAlD
Tretinoin—CYP4A11—endocrine gland—brain cancer	0.000456	0.0107	CbGeAlD
Tretinoin—ALDH1A1—gonad—brain cancer	0.000454	0.0106	CbGeAlD
Tretinoin—CRABP1—head—brain cancer	0.00045	0.0105	CbGeAlD
Tretinoin—RXRG—medulla oblongata—brain cancer	0.000449	0.0105	CbGeAlD
Tretinoin—RARA—telencephalon—brain cancer	0.000448	0.0105	CbGeAlD
Tretinoin—ALDH1A1—pituitary gland—brain cancer	0.000443	0.0104	CbGeAlD
Tretinoin—RARRES1—brain—brain cancer	0.00044	0.0103	CbGeAlD
Tretinoin—ALDH1A1—medulla oblongata—brain cancer	0.000428	0.01	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—brain cancer	0.000426	0.00997	CbGeAlD
Tretinoin—ALDH1A2—cerebellum—brain cancer	0.000416	0.00974	CbGeAlD
Tretinoin—CRABP2—endocrine gland—brain cancer	0.000412	0.00965	CbGeAlD
Tretinoin—CRABP1—central nervous system—brain cancer	0.000411	0.00962	CbGeAlD
Tretinoin—RXRA—endocrine gland—brain cancer	0.00041	0.00961	CbGeAlD
Tretinoin—RXRG—midbrain—brain cancer	0.00041	0.00961	CbGeAlD
Tretinoin—CRABP2—head—brain cancer	0.000407	0.00953	CbGeAlD
Tretinoin—RXRA—head—brain cancer	0.000405	0.00949	CbGeAlD
Tretinoin—CRABP1—cerebellum—brain cancer	0.000401	0.0094	CbGeAlD
Tretinoin—RXRG—spinal cord—brain cancer	0.0004	0.00937	CbGeAlD
Tretinoin—ALDH1A1—midbrain—brain cancer	0.000391	0.00916	CbGeAlD
Tretinoin—ALDH1A1—spinal cord—brain cancer	0.000381	0.00893	CbGeAlD
Tretinoin—NR0B1—brain—brain cancer	0.000379	0.00888	CbGeAlD
Tretinoin—RARA—gonad—brain cancer	0.000374	0.00876	CbGeAlD
Tretinoin—CRABP2—central nervous system—brain cancer	0.000371	0.0087	CbGeAlD
Tretinoin—RXRA—central nervous system—brain cancer	0.00037	0.00866	CbGeAlD
Tretinoin—RARB—endocrine gland—brain cancer	0.000369	0.00863	CbGeAlD
Tretinoin—RARA—pituitary gland—brain cancer	0.000365	0.00855	CbGeAlD
Tretinoin—RARB—head—brain cancer	0.000364	0.00852	CbGeAlD
Tretinoin—CRABP2—cerebellum—brain cancer	0.000363	0.0085	CbGeAlD
Tretinoin—RXRG—endocrine gland—brain cancer	0.00036	0.00844	CbGeAlD
Tretinoin—RXRG—head—brain cancer	0.000356	0.00833	CbGeAlD
Tretinoin—ALDH1A1—endocrine gland—brain cancer	0.000343	0.00804	CbGeAlD
Tretinoin—ALDH1A1—head—brain cancer	0.000339	0.00794	CbGeAlD
Tretinoin—RXRB—endocrine gland—brain cancer	0.000339	0.00793	CbGeAlD
Tretinoin—ALDH1A2—brain—brain cancer	0.000338	0.00791	CbGeAlD
Tretinoin—RXRB—head—brain cancer	0.000334	0.00783	CbGeAlD
Tretinoin—CRABP1—brain—brain cancer	0.000326	0.00764	CbGeAlD
Tretinoin—RARB—cerebellum—brain cancer	0.000325	0.0076	CbGeAlD
Tretinoin—RXRG—central nervous system—brain cancer	0.000325	0.0076	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—brain cancer	0.000309	0.00725	CbGeAlD
Tretinoin—RXRB—central nervous system—brain cancer	0.000305	0.00715	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—brain cancer	0.000302	0.00708	CbGeAlD
Tretinoin—CYP2C18—endocrine gland—brain cancer	0.000302	0.00707	CbGeAlD
Tretinoin—RXRB—cerebellum—brain cancer	0.000298	0.00699	CbGeAlD
Tretinoin—RARG—head—brain cancer	0.000297	0.00695	CbGeAlD
Tretinoin—CRABP2—brain—brain cancer	0.000295	0.00691	CbGeAlD
Tretinoin—RXRA—brain—brain cancer	0.000294	0.00688	CbGeAlD
Tretinoin—CYP3A7—endocrine gland—brain cancer	0.000287	0.00673	CbGeAlD
Tretinoin—RARA—endocrine gland—brain cancer	0.000283	0.00662	CbGeAlD
Tretinoin—RARA—head—brain cancer	0.000279	0.00654	CbGeAlD
Tretinoin—RARG—central nervous system—brain cancer	0.000271	0.00635	CbGeAlD
Tretinoin—RARG—cerebellum—brain cancer	0.000265	0.0062	CbGeAlD
Tretinoin—RARB—brain—brain cancer	0.000264	0.00618	CbGeAlD
Tretinoin—RXRG—brain—brain cancer	0.000258	0.00604	CbGeAlD
Tretinoin—RARA—central nervous system—brain cancer	0.000255	0.00597	CbGeAlD
Tretinoin—RARA—cerebellum—brain cancer	0.000249	0.00583	CbGeAlD
Tretinoin—ALDH1A1—brain—brain cancer	0.000246	0.00575	CbGeAlD
Tretinoin—RXRB—brain—brain cancer	0.000242	0.00567	CbGeAlD
Tretinoin—RARG—brain—brain cancer	0.000215	0.00504	CbGeAlD
Tretinoin—RARA—brain—brain cancer	0.000202	0.00474	CbGeAlD
Tretinoin—CYP2A6—cerebellum—brain cancer	0.000176	0.00412	CbGeAlD
Tretinoin—CYP2C8—pituitary gland—brain cancer	0.000145	0.00339	CbGeAlD
Tretinoin—CYP2A6—brain—brain cancer	0.000143	0.00334	CbGeAlD
Tretinoin—CYP2B6—gonad—brain cancer	0.000133	0.00311	CbGeAlD
Tretinoin—CYP2C8—endocrine gland—brain cancer	0.000112	0.00262	CbGeAlD
Tretinoin—Hypotension—Procarbazine—brain cancer	0.000105	0.00114	CcSEcCtD
Tretinoin—Neuropathy peripheral—Temozolomide—brain cancer	0.000105	0.00114	CcSEcCtD
Tretinoin—Stomatitis—Temozolomide—brain cancer	0.000104	0.00113	CcSEcCtD
Tretinoin—Urinary tract infection—Temozolomide—brain cancer	0.000104	0.00113	CcSEcCtD
Tretinoin—CYP1A1—endocrine gland—brain cancer	0.000103	0.00242	CbGeAlD
Tretinoin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000103	0.00112	CcSEcCtD
Tretinoin—CYP1A1—head—brain cancer	0.000102	0.00239	CbGeAlD
Tretinoin—Insomnia—Procarbazine—brain cancer	0.000102	0.00111	CcSEcCtD
Tretinoin—Paraesthesia—Procarbazine—brain cancer	0.000101	0.0011	CcSEcCtD
Tretinoin—CYP3A5—endocrine gland—brain cancer	0.000101	0.00237	CbGeAlD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000101	0.00171	CbGpPWpGaD
Tretinoin—CYP2B6—endocrine gland—brain cancer	0.0001	0.00235	CbGeAlD
Tretinoin—Sinusitis—Temozolomide—brain cancer	0.0001	0.00109	CcSEcCtD
Tretinoin—Somnolence—Procarbazine—brain cancer	0.0001	0.00109	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Etoposide—brain cancer	9.99e-05	0.00109	CcSEcCtD
Tretinoin—NR0B1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	9.99e-05	0.00169	CbGpPWpGaD
Tretinoin—Haemoglobin—Carmustine—brain cancer	9.98e-05	0.00108	CcSEcCtD
Tretinoin—CYP2C9—endocrine gland—brain cancer	9.95e-05	0.00233	CbGeAlD
Tretinoin—Haemorrhage—Carmustine—brain cancer	9.93e-05	0.00108	CcSEcCtD
Tretinoin—Ill-defined disorder—Hydroxyurea—brain cancer	9.92e-05	0.00108	CcSEcCtD
Tretinoin—CYP2B6—head—brain cancer	9.92e-05	0.00232	CbGeAlD
Tretinoin—Anaemia—Hydroxyurea—brain cancer	9.88e-05	0.00107	CcSEcCtD
Tretinoin—Hallucination—Carmustine—brain cancer	9.88e-05	0.00107	CcSEcCtD
Tretinoin—Hypoaesthesia—Carmustine—brain cancer	9.88e-05	0.00107	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.83e-05	0.00166	CbGpPWpGaD
Tretinoin—Decreased appetite—Procarbazine—brain cancer	9.8e-05	0.00106	CcSEcCtD
Tretinoin—Oedema peripheral—Carmustine—brain cancer	9.78e-05	0.00106	CcSEcCtD
Tretinoin—Fatigue—Procarbazine—brain cancer	9.72e-05	0.00106	CcSEcCtD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.69e-05	0.00164	CbGpPWpGaD
Tretinoin—Haemoglobin—Temozolomide—brain cancer	9.64e-05	0.00105	CcSEcCtD
Tretinoin—Malaise—Hydroxyurea—brain cancer	9.64e-05	0.00105	CcSEcCtD
Tretinoin—Pain—Procarbazine—brain cancer	9.64e-05	0.00105	CcSEcCtD
Tretinoin—Constipation—Procarbazine—brain cancer	9.64e-05	0.00105	CcSEcCtD
Tretinoin—Haemorrhage—Temozolomide—brain cancer	9.59e-05	0.00104	CcSEcCtD
Tretinoin—Hepatitis—Temozolomide—brain cancer	9.59e-05	0.00104	CcSEcCtD
Tretinoin—Dysphagia—Etoposide—brain cancer	9.59e-05	0.00104	CcSEcCtD
Tretinoin—Visual impairment—Carmustine—brain cancer	9.57e-05	0.00104	CcSEcCtD
Tretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	9.55e-05	0.00161	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.55e-05	0.00161	CbGpPWpGaD
Tretinoin—Hypoaesthesia—Temozolomide—brain cancer	9.55e-05	0.00104	CcSEcCtD
Tretinoin—Hallucination—Temozolomide—brain cancer	9.55e-05	0.00104	CcSEcCtD
Tretinoin—Pharyngitis—Temozolomide—brain cancer	9.52e-05	0.00103	CcSEcCtD
Tretinoin—Urinary tract disorder—Temozolomide—brain cancer	9.48e-05	0.00103	CcSEcCtD
Tretinoin—Oedema peripheral—Temozolomide—brain cancer	9.45e-05	0.00103	CcSEcCtD
Tretinoin—Bronchospasm—Etoposide—brain cancer	9.43e-05	0.00102	CcSEcCtD
Tretinoin—Urethral disorder—Temozolomide—brain cancer	9.41e-05	0.00102	CcSEcCtD
Tretinoin—CYP4A11—PPAR Alpha Pathway—MYC—brain cancer	9.35e-05	0.00158	CbGpPWpGaD
Tretinoin—Sweating increased—Etoposide—brain cancer	9.34e-05	0.00101	CcSEcCtD
Tretinoin—CYP1A1—central nervous system—brain cancer	9.32e-05	0.00218	CbGeAlD
Tretinoin—Feeling abnormal—Procarbazine—brain cancer	9.29e-05	0.00101	CcSEcCtD
Tretinoin—Eye disorder—Carmustine—brain cancer	9.28e-05	0.00101	CcSEcCtD
Tretinoin—Convulsion—Hydroxyurea—brain cancer	9.26e-05	0.00101	CcSEcCtD
Tretinoin—RXRA—PPAR Alpha Pathway—CCND1—brain cancer	9.25e-05	0.00156	CbGpPWpGaD
Tretinoin—Visual impairment—Temozolomide—brain cancer	9.25e-05	0.001	CcSEcCtD
Tretinoin—Gastrointestinal pain—Procarbazine—brain cancer	9.22e-05	0.001	CcSEcCtD
Tretinoin—Flushing—Carmustine—brain cancer	9.21e-05	0.001	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.15e-05	0.00155	CbGpPWpGaD
Tretinoin—Erythema multiforme—Temozolomide—brain cancer	9.07e-05	0.000985	CcSEcCtD
Tretinoin—CYP2B6—central nervous system—brain cancer	9.05e-05	0.00212	CbGeAlD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	9.04e-05	0.000982	CcSEcCtD
Tretinoin—Discomfort—Hydroxyurea—brain cancer	8.99e-05	0.000977	CcSEcCtD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	8.98e-05	0.00152	CbGpPWpGaD
Tretinoin—Neutropenia—Etoposide—brain cancer	8.97e-05	0.000974	CcSEcCtD
Tretinoin—Eye disorder—Temozolomide—brain cancer	8.97e-05	0.000974	CcSEcCtD
Tretinoin—Urticaria—Procarbazine—brain cancer	8.96e-05	0.000973	CcSEcCtD
Tretinoin—Tinnitus—Temozolomide—brain cancer	8.95e-05	0.000971	CcSEcCtD
Tretinoin—Abdominal pain—Procarbazine—brain cancer	8.91e-05	0.000968	CcSEcCtD
Tretinoin—Body temperature increased—Procarbazine—brain cancer	8.91e-05	0.000968	CcSEcCtD
Tretinoin—Flushing—Temozolomide—brain cancer	8.9e-05	0.000967	CcSEcCtD
Tretinoin—Arrhythmia—Carmustine—brain cancer	8.87e-05	0.000963	CcSEcCtD
Tretinoin—Alopecia—Carmustine—brain cancer	8.77e-05	0.000953	CcSEcCtD
Tretinoin—Oedema—Hydroxyurea—brain cancer	8.73e-05	0.000948	CcSEcCtD
Tretinoin—Angiopathy—Temozolomide—brain cancer	8.71e-05	0.000945	CcSEcCtD
Tretinoin—Mental disorder—Carmustine—brain cancer	8.7e-05	0.000945	CcSEcCtD
Tretinoin—Infection—Hydroxyurea—brain cancer	8.67e-05	0.000941	CcSEcCtD
Tretinoin—Malnutrition—Carmustine—brain cancer	8.64e-05	0.000939	CcSEcCtD
Tretinoin—Erythema—Carmustine—brain cancer	8.64e-05	0.000939	CcSEcCtD
Tretinoin—Chills—Temozolomide—brain cancer	8.61e-05	0.000935	CcSEcCtD
Tretinoin—Pneumonia—Etoposide—brain cancer	8.6e-05	0.000934	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—IRS2—brain cancer	8.6e-05	0.00145	CbGpPWpGaD
Tretinoin—Nervous system disorder—Hydroxyurea—brain cancer	8.56e-05	0.000929	CcSEcCtD
Tretinoin—Infestation—Etoposide—brain cancer	8.55e-05	0.000929	CcSEcCtD
Tretinoin—Infestation NOS—Etoposide—brain cancer	8.55e-05	0.000929	CcSEcCtD
Tretinoin—Thrombocytopenia—Hydroxyurea—brain cancer	8.54e-05	0.000928	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Etoposide—brain cancer	8.48e-05	0.000921	CcSEcCtD
Tretinoin—Alopecia—Temozolomide—brain cancer	8.48e-05	0.000921	CcSEcCtD
Tretinoin—Skin disorder—Hydroxyurea—brain cancer	8.48e-05	0.00092	CcSEcCtD
Tretinoin—Acute coronary syndrome—Etoposide—brain cancer	8.43e-05	0.000916	CcSEcCtD
Tretinoin—Renal failure—Etoposide—brain cancer	8.41e-05	0.000913	CcSEcCtD
Tretinoin—Mental disorder—Temozolomide—brain cancer	8.41e-05	0.000913	CcSEcCtD
Tretinoin—Neuropathy peripheral—Etoposide—brain cancer	8.38e-05	0.00091	CcSEcCtD
Tretinoin—Myocardial infarction—Etoposide—brain cancer	8.38e-05	0.00091	CcSEcCtD
Tretinoin—Back pain—Carmustine—brain cancer	8.36e-05	0.000908	CcSEcCtD
Tretinoin—Malnutrition—Temozolomide—brain cancer	8.35e-05	0.000907	CcSEcCtD
Tretinoin—Erythema—Temozolomide—brain cancer	8.35e-05	0.000907	CcSEcCtD
Tretinoin—Stomatitis—Etoposide—brain cancer	8.34e-05	0.000905	CcSEcCtD
Tretinoin—Anorexia—Hydroxyurea—brain cancer	8.32e-05	0.000903	CcSEcCtD
Tretinoin—Hypersensitivity—Procarbazine—brain cancer	8.31e-05	0.000902	CcSEcCtD
Tretinoin—CYP3A7—Biological oxidations—CYP2C9—brain cancer	8.22e-05	0.00139	CbGpPWpGaD
Tretinoin—Vision blurred—Carmustine—brain cancer	8.15e-05	0.000885	CcSEcCtD
Tretinoin—CYP1A1—Oxidative Stress—SOD2—brain cancer	8.13e-05	0.00137	CbGpPWpGaD
Tretinoin—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	8.11e-05	0.00137	CbGpPWpGaD
Tretinoin—Tremor—Carmustine—brain cancer	8.1e-05	0.000879	CcSEcCtD
Tretinoin—Asthenia—Procarbazine—brain cancer	8.09e-05	0.000878	CcSEcCtD
Tretinoin—RARA—Adipogenesis—IRS2—brain cancer	8.08e-05	0.00137	CbGpPWpGaD
Tretinoin—Back pain—Temozolomide—brain cancer	8.08e-05	0.000877	CcSEcCtD
Tretinoin—CYP2C8—brain—brain cancer	8.01e-05	0.00188	CbGeAlD
Tretinoin—Anaemia—Carmustine—brain cancer	7.99e-05	0.000867	CcSEcCtD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	7.99e-05	0.00135	CbGpPWpGaD
Tretinoin—Agranulocytosis—Etoposide—brain cancer	7.98e-05	0.000867	CcSEcCtD
Tretinoin—Pruritus—Procarbazine—brain cancer	7.98e-05	0.000866	CcSEcCtD
Tretinoin—Agitation—Carmustine—brain cancer	7.94e-05	0.000863	CcSEcCtD
Tretinoin—Vision blurred—Temozolomide—brain cancer	7.87e-05	0.000855	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.84e-05	0.00132	CbGpPWpGaD
Tretinoin—Tremor—Temozolomide—brain cancer	7.83e-05	0.00085	CcSEcCtD
Tretinoin—Dyspnoea—Hydroxyurea—brain cancer	7.78e-05	0.000845	CcSEcCtD
Tretinoin—Somnolence—Hydroxyurea—brain cancer	7.76e-05	0.000842	CcSEcCtD
Tretinoin—Ill-defined disorder—Temozolomide—brain cancer	7.75e-05	0.000842	CcSEcCtD
Tretinoin—Anaemia—Temozolomide—brain cancer	7.72e-05	0.000838	CcSEcCtD
Tretinoin—Diarrhoea—Procarbazine—brain cancer	7.71e-05	0.000838	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.69e-05	0.0013	CbGpPWpGaD
Tretinoin—Dyspepsia—Hydroxyurea—brain cancer	7.68e-05	0.000834	CcSEcCtD
Tretinoin—Agitation—Temozolomide—brain cancer	7.68e-05	0.000834	CcSEcCtD
Tretinoin—Hypoaesthesia—Etoposide—brain cancer	7.64e-05	0.00083	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.59e-05	0.00128	CbGpPWpGaD
Tretinoin—CYP3A4—endocrine gland—brain cancer	7.59e-05	0.00178	CbGeAlD
Tretinoin—Decreased appetite—Hydroxyurea—brain cancer	7.59e-05	0.000824	CcSEcCtD
Tretinoin—Urinary tract disorder—Etoposide—brain cancer	7.58e-05	0.000823	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Hydroxyurea—brain cancer	7.53e-05	0.000818	CcSEcCtD
Tretinoin—CYP2A6—Biological oxidations—CYP2C9—brain cancer	7.53e-05	0.00127	CbGpPWpGaD
Tretinoin—Malaise—Temozolomide—brain cancer	7.53e-05	0.000818	CcSEcCtD
Tretinoin—Urethral disorder—Etoposide—brain cancer	7.53e-05	0.000817	CcSEcCtD
Tretinoin—Fatigue—Hydroxyurea—brain cancer	7.52e-05	0.000817	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.52e-05	0.00127	CbGpPWpGaD
Tretinoin—Convulsion—Carmustine—brain cancer	7.49e-05	0.000813	CcSEcCtD
Tretinoin—Hypertension—Carmustine—brain cancer	7.46e-05	0.00081	CcSEcCtD
Tretinoin—Constipation—Hydroxyurea—brain cancer	7.46e-05	0.00081	CcSEcCtD
Tretinoin—Pain—Hydroxyurea—brain cancer	7.46e-05	0.00081	CcSEcCtD
Tretinoin—Dizziness—Procarbazine—brain cancer	7.46e-05	0.00081	CcSEcCtD
Tretinoin—RXRA—PPAR Alpha Pathway—MYC—brain cancer	7.42e-05	0.00125	CbGpPWpGaD
Tretinoin—CYP1A1—brain—brain cancer	7.4e-05	0.00173	CbGeAlD
Tretinoin—Palpitations—Temozolomide—brain cancer	7.38e-05	0.000802	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.37e-05	0.00125	CbGpPWpGaD
Tretinoin—Chest pain—Carmustine—brain cancer	7.36e-05	0.000799	CcSEcCtD
Tretinoin—Myalgia—Carmustine—brain cancer	7.36e-05	0.000799	CcSEcCtD
Tretinoin—Anxiety—Carmustine—brain cancer	7.33e-05	0.000796	CcSEcCtD
Tretinoin—Cough—Temozolomide—brain cancer	7.29e-05	0.000791	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.28e-05	0.00123	CbGpPWpGaD
Tretinoin—Erythema multiforme—Etoposide—brain cancer	7.26e-05	0.000788	CcSEcCtD
Tretinoin—Convulsion—Temozolomide—brain cancer	7.24e-05	0.000786	CcSEcCtD
Tretinoin—Hypertension—Temozolomide—brain cancer	7.21e-05	0.000783	CcSEcCtD
Tretinoin—Feeling abnormal—Hydroxyurea—brain cancer	7.19e-05	0.000781	CcSEcCtD
Tretinoin—CYP2B6—brain—brain cancer	7.19e-05	0.00168	CbGeAlD
Tretinoin—Eye disorder—Etoposide—brain cancer	7.17e-05	0.000779	CcSEcCtD
Tretinoin—Vomiting—Procarbazine—brain cancer	7.17e-05	0.000778	CcSEcCtD
Tretinoin—Flushing—Etoposide—brain cancer	7.13e-05	0.000774	CcSEcCtD
Tretinoin—Confusional state—Carmustine—brain cancer	7.11e-05	0.000772	CcSEcCtD
Tretinoin—Arthralgia—Temozolomide—brain cancer	7.11e-05	0.000772	CcSEcCtD
Tretinoin—Myalgia—Temozolomide—brain cancer	7.11e-05	0.000772	CcSEcCtD
Tretinoin—Rash—Procarbazine—brain cancer	7.11e-05	0.000772	CcSEcCtD
Tretinoin—Dermatitis—Procarbazine—brain cancer	7.1e-05	0.000771	CcSEcCtD
Tretinoin—Anxiety—Temozolomide—brain cancer	7.09e-05	0.00077	CcSEcCtD
Tretinoin—Headache—Procarbazine—brain cancer	7.06e-05	0.000767	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	7.06e-05	0.000767	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.06e-05	0.00119	CbGpPWpGaD
Tretinoin—Oedema—Carmustine—brain cancer	7.05e-05	0.000766	CcSEcCtD
Tretinoin—Discomfort—Temozolomide—brain cancer	7.03e-05	0.000763	CcSEcCtD
Tretinoin—Infection—Carmustine—brain cancer	7.01e-05	0.000761	CcSEcCtD
Tretinoin—Angiopathy—Etoposide—brain cancer	6.97e-05	0.000756	CcSEcCtD
Tretinoin—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	6.96e-05	0.00117	CbGpPWpGaD
Tretinoin—Dry mouth—Temozolomide—brain cancer	6.95e-05	0.000755	CcSEcCtD
Tretinoin—Thrombocytopenia—Carmustine—brain cancer	6.91e-05	0.00075	CcSEcCtD
Tretinoin—Body temperature increased—Hydroxyurea—brain cancer	6.9e-05	0.000749	CcSEcCtD
Tretinoin—Chills—Etoposide—brain cancer	6.89e-05	0.000748	CcSEcCtD
Tretinoin—Tachycardia—Carmustine—brain cancer	6.88e-05	0.000748	CcSEcCtD
Tretinoin—Confusional state—Temozolomide—brain cancer	6.87e-05	0.000746	CcSEcCtD
Tretinoin—CYP3A4—central nervous system—brain cancer	6.84e-05	0.0016	CbGeAlD
Tretinoin—Oedema—Temozolomide—brain cancer	6.82e-05	0.00074	CcSEcCtD
Tretinoin—Anaphylactic shock—Temozolomide—brain cancer	6.82e-05	0.00074	CcSEcCtD
Tretinoin—Alopecia—Etoposide—brain cancer	6.78e-05	0.000737	CcSEcCtD
Tretinoin—Infection—Temozolomide—brain cancer	6.77e-05	0.000735	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.77e-05	0.00114	CbGpPWpGaD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	6.75e-05	0.00114	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.73e-05	0.00114	CbGpPWpGaD
Tretinoin—Anorexia—Carmustine—brain cancer	6.72e-05	0.00073	CcSEcCtD
Tretinoin—Nausea—Procarbazine—brain cancer	6.7e-05	0.000727	CcSEcCtD
Tretinoin—Nervous system disorder—Temozolomide—brain cancer	6.68e-05	0.000726	CcSEcCtD
Tretinoin—Thrombocytopenia—Temozolomide—brain cancer	6.67e-05	0.000725	CcSEcCtD
Tretinoin—Skin disorder—Temozolomide—brain cancer	6.62e-05	0.000719	CcSEcCtD
Tretinoin—Hypotension—Carmustine—brain cancer	6.59e-05	0.000716	CcSEcCtD
Tretinoin—Hyperhidrosis—Temozolomide—brain cancer	6.59e-05	0.000716	CcSEcCtD
Tretinoin—NR0B1—Generic Transcription Pathway—ESR2—brain cancer	6.56e-05	0.00111	CbGpPWpGaD
Tretinoin—Anorexia—Temozolomide—brain cancer	6.5e-05	0.000706	CcSEcCtD
Tretinoin—Back pain—Etoposide—brain cancer	6.46e-05	0.000702	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.45e-05	0.00109	CbGpPWpGaD
Tretinoin—Hypersensitivity—Hydroxyurea—brain cancer	6.43e-05	0.000698	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Carmustine—brain cancer	6.43e-05	0.000698	CcSEcCtD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.41e-05	0.00108	CbGpPWpGaD
Tretinoin—Insomnia—Carmustine—brain cancer	6.38e-05	0.000693	CcSEcCtD
Tretinoin—CRABP2—Metabolism—CYP2C9—brain cancer	6.34e-05	0.00107	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP2C9—brain cancer	6.34e-05	0.00107	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP2C9—brain cancer	6.34e-05	0.00107	CbGpPWpGaD
Tretinoin—Paraesthesia—Carmustine—brain cancer	6.33e-05	0.000688	CcSEcCtD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.33e-05	0.00107	CbGpPWpGaD
Tretinoin—Dyspnoea—Carmustine—brain cancer	6.29e-05	0.000683	CcSEcCtD
Tretinoin—Somnolence—Carmustine—brain cancer	6.27e-05	0.000681	CcSEcCtD
Tretinoin—Asthenia—Hydroxyurea—brain cancer	6.26e-05	0.00068	CcSEcCtD
Tretinoin—NR0B1—Generic Transcription Pathway—NOTCH2—brain cancer	6.21e-05	0.00105	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Temozolomide—brain cancer	6.21e-05	0.000674	CcSEcCtD
Tretinoin—Ill-defined disorder—Etoposide—brain cancer	6.2e-05	0.000673	CcSEcCtD
Tretinoin—Anaemia—Etoposide—brain cancer	6.18e-05	0.000671	CcSEcCtD
Tretinoin—Insomnia—Temozolomide—brain cancer	6.17e-05	0.00067	CcSEcCtD
Tretinoin—Decreased appetite—Carmustine—brain cancer	6.13e-05	0.000666	CcSEcCtD
Tretinoin—Paraesthesia—Temozolomide—brain cancer	6.12e-05	0.000665	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Carmustine—brain cancer	6.09e-05	0.000661	CcSEcCtD
Tretinoin—CYP2B6—Biological oxidations—CYP2C9—brain cancer	6.08e-05	0.00103	CbGpPWpGaD
Tretinoin—Dyspnoea—Temozolomide—brain cancer	6.08e-05	0.00066	CcSEcCtD
Tretinoin—Somnolence—Temozolomide—brain cancer	6.06e-05	0.000658	CcSEcCtD
Tretinoin—Pain—Carmustine—brain cancer	6.03e-05	0.000655	CcSEcCtD
Tretinoin—Constipation—Carmustine—brain cancer	6.03e-05	0.000655	CcSEcCtD
Tretinoin—Malaise—Etoposide—brain cancer	6.03e-05	0.000655	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	6.01e-05	0.00102	CbGpPWpGaD
Tretinoin—Dyspepsia—Temozolomide—brain cancer	6e-05	0.000652	CcSEcCtD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	5.99e-05	0.00101	CbGpPWpGaD
Tretinoin—Diarrhoea—Hydroxyurea—brain cancer	5.97e-05	0.000648	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.96e-05	0.00101	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	5.94e-05	0.001	CbGpPWpGaD
Tretinoin—Decreased appetite—Temozolomide—brain cancer	5.93e-05	0.000643	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Temozolomide—brain cancer	5.88e-05	0.000639	CcSEcCtD
Tretinoin—Fatigue—Temozolomide—brain cancer	5.88e-05	0.000638	CcSEcCtD
Tretinoin—Loss of consciousness—Etoposide—brain cancer	5.87e-05	0.000638	CcSEcCtD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	5.86e-05	0.00099	CbGpPWpGaD
Tretinoin—Cough—Etoposide—brain cancer	5.83e-05	0.000633	CcSEcCtD
Tretinoin—Pain—Temozolomide—brain cancer	5.83e-05	0.000633	CcSEcCtD
Tretinoin—Constipation—Temozolomide—brain cancer	5.83e-05	0.000633	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.81e-05	0.000982	CbGpPWpGaD
Tretinoin—Feeling abnormal—Carmustine—brain cancer	5.81e-05	0.000631	CcSEcCtD
Tretinoin—Convulsion—Etoposide—brain cancer	5.79e-05	0.000629	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.79e-05	0.000978	CbGpPWpGaD
Tretinoin—Hypertension—Etoposide—brain cancer	5.77e-05	0.000627	CcSEcCtD
Tretinoin—Dizziness—Hydroxyurea—brain cancer	5.77e-05	0.000627	CcSEcCtD
Tretinoin—Gastrointestinal pain—Carmustine—brain cancer	5.77e-05	0.000626	CcSEcCtD
Tretinoin—Chest pain—Etoposide—brain cancer	5.69e-05	0.000618	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.65e-05	0.000955	CbGpPWpGaD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	5.65e-05	0.000614	CcSEcCtD
Tretinoin—Discomfort—Etoposide—brain cancer	5.62e-05	0.00061	CcSEcCtD
Tretinoin—Feeling abnormal—Temozolomide—brain cancer	5.62e-05	0.00061	CcSEcCtD
Tretinoin—CYP1A1—Biological oxidations—CYP2C9—brain cancer	5.61e-05	0.000948	CbGpPWpGaD
Tretinoin—Abdominal pain—Carmustine—brain cancer	5.58e-05	0.000606	CcSEcCtD
Tretinoin—Body temperature increased—Carmustine—brain cancer	5.58e-05	0.000606	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.57e-05	0.000942	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Temozolomide—brain cancer	5.57e-05	0.000605	CcSEcCtD
Tretinoin—Vomiting—Hydroxyurea—brain cancer	5.55e-05	0.000602	CcSEcCtD
Tretinoin—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	5.54e-05	0.000935	CbGpPWpGaD
Tretinoin—Rash—Hydroxyurea—brain cancer	5.5e-05	0.000597	CcSEcCtD
Tretinoin—Confusional state—Etoposide—brain cancer	5.5e-05	0.000597	CcSEcCtD
Tretinoin—Dermatitis—Hydroxyurea—brain cancer	5.5e-05	0.000597	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.47e-05	0.000925	CbGpPWpGaD
Tretinoin—Headache—Hydroxyurea—brain cancer	5.47e-05	0.000594	CcSEcCtD
Tretinoin—Anaphylactic shock—Etoposide—brain cancer	5.45e-05	0.000592	CcSEcCtD
Tretinoin—CYP3A4—Irinotecan Pathway—APC—brain cancer	5.45e-05	0.00092	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.43e-05	0.000917	CbGpPWpGaD
Tretinoin—Infection—Etoposide—brain cancer	5.42e-05	0.000588	CcSEcCtD
Tretinoin—Urticaria—Temozolomide—brain cancer	5.42e-05	0.000588	CcSEcCtD
Tretinoin—Body temperature increased—Temozolomide—brain cancer	5.39e-05	0.000585	CcSEcCtD
Tretinoin—Abdominal pain—Temozolomide—brain cancer	5.39e-05	0.000585	CcSEcCtD
Tretinoin—CRABP2—Metabolism—BSG—brain cancer	5.39e-05	0.00091	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—BSG—brain cancer	5.39e-05	0.00091	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—BSG—brain cancer	5.39e-05	0.00091	CbGpPWpGaD
Tretinoin—Thrombocytopenia—Etoposide—brain cancer	5.34e-05	0.00058	CcSEcCtD
Tretinoin—Tachycardia—Etoposide—brain cancer	5.32e-05	0.000578	CcSEcCtD
Tretinoin—Skin disorder—Etoposide—brain cancer	5.3e-05	0.000575	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—ESR2—brain cancer	5.29e-05	0.000893	CbGpPWpGaD
Tretinoin—Hyperhidrosis—Etoposide—brain cancer	5.27e-05	0.000573	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.25e-05	0.000886	CbGpPWpGaD
Tretinoin—Anorexia—Etoposide—brain cancer	5.2e-05	0.000565	CcSEcCtD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.2e-05	0.000878	CbGpPWpGaD
Tretinoin—Hypersensitivity—Carmustine—brain cancer	5.2e-05	0.000564	CcSEcCtD
Tretinoin—Nausea—Hydroxyurea—brain cancer	5.18e-05	0.000563	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—CTNNB1—brain cancer	5.16e-05	0.000871	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	5.15e-05	0.000869	CbGpPWpGaD
Tretinoin—Hypotension—Etoposide—brain cancer	5.1e-05	0.000553	CcSEcCtD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	5.07e-05	0.000857	CbGpPWpGaD
Tretinoin—Asthenia—Carmustine—brain cancer	5.06e-05	0.00055	CcSEcCtD
Tretinoin—Hypersensitivity—Temozolomide—brain cancer	5.02e-05	0.000545	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—NOTCH2—brain cancer	5.01e-05	0.000846	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—S100A10—brain cancer	4.94e-05	0.000835	CbGpPWpGaD
Tretinoin—Paraesthesia—Etoposide—brain cancer	4.9e-05	0.000532	CcSEcCtD
Tretinoin—Asthenia—Temozolomide—brain cancer	4.89e-05	0.000531	CcSEcCtD
Tretinoin—Dyspnoea—Etoposide—brain cancer	4.86e-05	0.000528	CcSEcCtD
Tretinoin—RARA—Adipogenesis—CTNNB1—brain cancer	4.85e-05	0.000819	CbGpPWpGaD
Tretinoin—Somnolence—Etoposide—brain cancer	4.85e-05	0.000527	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—ESR2—brain cancer	4.84e-05	0.000817	CbGpPWpGaD
Tretinoin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	4.83e-05	0.000816	CbGpPWpGaD
Tretinoin—Diarrhoea—Carmustine—brain cancer	4.83e-05	0.000524	CcSEcCtD
Tretinoin—Pruritus—Temozolomide—brain cancer	4.82e-05	0.000524	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.77e-05	0.000806	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—ESR2—brain cancer	4.74e-05	0.000801	CbGpPWpGaD
Tretinoin—Decreased appetite—Etoposide—brain cancer	4.74e-05	0.000515	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Etoposide—brain cancer	4.71e-05	0.000511	CcSEcCtD
Tretinoin—Fatigue—Etoposide—brain cancer	4.7e-05	0.000511	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	4.68e-05	0.00079	CbGpPWpGaD
Tretinoin—Dizziness—Carmustine—brain cancer	4.66e-05	0.000507	CcSEcCtD
Tretinoin—Constipation—Etoposide—brain cancer	4.66e-05	0.000507	CcSEcCtD
Tretinoin—Pain—Etoposide—brain cancer	4.66e-05	0.000507	CcSEcCtD
Tretinoin—Diarrhoea—Temozolomide—brain cancer	4.66e-05	0.000506	CcSEcCtD
Tretinoin—CRABP2—Metabolism—IDH1—brain cancer	4.63e-05	0.000783	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—IDH1—brain cancer	4.63e-05	0.000783	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—IDH1—brain cancer	4.63e-05	0.000783	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—NOTCH2—brain cancer	4.58e-05	0.000774	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—ESR2—brain cancer	4.55e-05	0.000768	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—ESR2—brain cancer	4.55e-05	0.000768	CbGpPWpGaD
Tretinoin—Dizziness—Temozolomide—brain cancer	4.51e-05	0.00049	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—STAT3—brain cancer	4.5e-05	0.00076	CbGpPWpGaD
Tretinoin—Feeling abnormal—Etoposide—brain cancer	4.49e-05	0.000488	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—NOTCH2—brain cancer	4.49e-05	0.000759	CbGpPWpGaD
Tretinoin—Vomiting—Carmustine—brain cancer	4.48e-05	0.000487	CcSEcCtD
Tretinoin—Gastrointestinal pain—Etoposide—brain cancer	4.46e-05	0.000484	CcSEcCtD
Tretinoin—Rash—Carmustine—brain cancer	4.45e-05	0.000483	CcSEcCtD
Tretinoin—Dermatitis—Carmustine—brain cancer	4.44e-05	0.000483	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	4.42e-05	0.000747	CbGpPWpGaD
Tretinoin—Headache—Carmustine—brain cancer	4.42e-05	0.00048	CcSEcCtD
Tretinoin—Vomiting—Temozolomide—brain cancer	4.33e-05	0.000471	CcSEcCtD
Tretinoin—Urticaria—Etoposide—brain cancer	4.33e-05	0.000471	CcSEcCtD
Tretinoin—Abdominal pain—Etoposide—brain cancer	4.31e-05	0.000468	CcSEcCtD
Tretinoin—Body temperature increased—Etoposide—brain cancer	4.31e-05	0.000468	CcSEcCtD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.31e-05	0.000728	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—NOTCH2—brain cancer	4.31e-05	0.000727	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NOTCH2—brain cancer	4.31e-05	0.000727	CbGpPWpGaD
Tretinoin—Rash—Temozolomide—brain cancer	4.3e-05	0.000467	CcSEcCtD
Tretinoin—Dermatitis—Temozolomide—brain cancer	4.29e-05	0.000466	CcSEcCtD
Tretinoin—Headache—Temozolomide—brain cancer	4.27e-05	0.000464	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.25e-05	0.000718	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—STAT3—brain cancer	4.23e-05	0.000714	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IRS2—brain cancer	4.21e-05	0.000712	CbGpPWpGaD
Tretinoin—Nausea—Carmustine—brain cancer	4.19e-05	0.000455	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.07e-05	0.000688	CbGpPWpGaD
Tretinoin—Nausea—Temozolomide—brain cancer	4.05e-05	0.00044	CcSEcCtD
Tretinoin—Hypersensitivity—Etoposide—brain cancer	4.02e-05	0.000436	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.97e-05	0.000671	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.92e-05	0.000662	CbGpPWpGaD
Tretinoin—Asthenia—Etoposide—brain cancer	3.91e-05	0.000425	CcSEcCtD
Tretinoin—Pruritus—Etoposide—brain cancer	3.86e-05	0.000419	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.84e-05	0.000649	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.79e-05	0.000641	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.77e-05	0.000637	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.77e-05	0.000637	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.75e-05	0.000634	CbGpPWpGaD
Tretinoin—Diarrhoea—Etoposide—brain cancer	3.73e-05	0.000405	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.72e-05	0.000628	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ENO2—brain cancer	3.66e-05	0.000619	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ENO2—brain cancer	3.66e-05	0.000619	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ENO2—brain cancer	3.66e-05	0.000619	CbGpPWpGaD
Tretinoin—Dizziness—Etoposide—brain cancer	3.61e-05	0.000392	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.6e-05	0.000608	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.57e-05	0.000602	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.53e-05	0.000596	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—DNMT1—brain cancer	3.52e-05	0.000594	CbGpPWpGaD
Tretinoin—Vomiting—Etoposide—brain cancer	3.47e-05	0.000377	CcSEcCtD
Tretinoin—Rash—Etoposide—brain cancer	3.44e-05	0.000373	CcSEcCtD
Tretinoin—Dermatitis—Etoposide—brain cancer	3.44e-05	0.000373	CcSEcCtD
Tretinoin—Headache—Etoposide—brain cancer	3.42e-05	0.000371	CcSEcCtD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	3.38e-05	0.000571	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.36e-05	0.000568	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.34e-05	0.000564	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.27e-05	0.000553	CbGpPWpGaD
Tretinoin—Nausea—Etoposide—brain cancer	3.24e-05	0.000352	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—ESR2—brain cancer	3.16e-05	0.000534	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.15e-05	0.000532	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.14e-05	0.00053	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.01e-05	0.000509	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.01e-05	0.000508	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—NOTCH2—brain cancer	2.99e-05	0.000505	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.95e-05	0.000498	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.91e-05	0.000491	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.89e-05	0.000488	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—DNMT1—brain cancer	2.84e-05	0.000479	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.82e-05	0.000477	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	2.76e-05	0.000467	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.73e-05	0.000462	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	2.72e-05	0.00046	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TRPC6—brain cancer	2.69e-05	0.000454	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—DNMT1—brain cancer	2.59e-05	0.000438	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.56e-05	0.000432	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—ESR2—brain cancer	2.55e-05	0.00043	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—DNMT1—brain cancer	2.54e-05	0.00043	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—SIRT1—brain cancer	2.54e-05	0.00043	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—CTNNB1—brain cancer	2.53e-05	0.000427	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.47e-05	0.000418	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—DNMT1—brain cancer	2.44e-05	0.000412	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—DNMT1—brain cancer	2.44e-05	0.000412	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP2C9—brain cancer	2.42e-05	0.000409	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NOTCH2—brain cancer	2.41e-05	0.000407	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.37e-05	0.000401	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—ESR2—brain cancer	2.37e-05	0.0004	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.35e-05	0.000397	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—ESR2—brain cancer	2.33e-05	0.000393	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.3e-05	0.000389	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.3e-05	0.000389	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—ESR2—brain cancer	2.28e-05	0.000386	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—TRPC6—brain cancer	2.28e-05	0.000386	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NOTCH2—brain cancer	2.24e-05	0.000379	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NOTCH2—brain cancer	2.21e-05	0.000373	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT3—brain cancer	2.2e-05	0.000372	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—ESR2—brain cancer	2.19e-05	0.00037	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—ESR2—brain cancer	2.19e-05	0.00037	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NOTCH2—brain cancer	2.16e-05	0.000365	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.16e-05	0.000364	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.12e-05	0.000359	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP2C9—brain cancer	2.11e-05	0.000357	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NOTCH2—brain cancer	2.07e-05	0.00035	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NOTCH2—brain cancer	2.07e-05	0.00035	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—MYC—brain cancer	2.07e-05	0.00035	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—BSG—brain cancer	2.06e-05	0.000347	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—SIRT1—brain cancer	2.05e-05	0.000346	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.98e-05	0.000334	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP2C9—brain cancer	1.92e-05	0.000324	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.88e-05	0.000317	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—SIRT1—brain cancer	1.88e-05	0.000317	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.86e-05	0.000314	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—SIRT1—brain cancer	1.84e-05	0.000311	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—BSG—brain cancer	1.8e-05	0.000304	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—IDH1—brain cancer	1.77e-05	0.000299	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—SIRT1—brain cancer	1.76e-05	0.000298	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—SIRT1—brain cancer	1.76e-05	0.000298	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HES1—brain cancer	1.73e-05	0.000293	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CG—brain cancer	1.68e-05	0.000284	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CG—brain cancer	1.68e-05	0.000284	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CG—brain cancer	1.68e-05	0.000284	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—MYC—brain cancer	1.67e-05	0.000282	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.64e-05	0.000276	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—BSG—brain cancer	1.63e-05	0.000276	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.58e-05	0.000266	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—IDH1—brain cancer	1.55e-05	0.000261	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—MYC—brain cancer	1.53e-05	0.000258	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.5e-05	0.000254	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—MYC—brain cancer	1.5e-05	0.000253	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.47e-05	0.000249	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.44e-05	0.000244	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.44e-05	0.000243	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—MYC—brain cancer	1.43e-05	0.000242	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—MYC—brain cancer	1.43e-05	0.000242	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP2C9—brain cancer	1.41e-05	0.000237	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—IDH1—brain cancer	1.4e-05	0.000237	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ENO2—brain cancer	1.4e-05	0.000236	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CDK4—brain cancer	1.36e-05	0.000229	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000218	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—DNMT1—brain cancer	1.27e-05	0.000215	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.24e-05	0.000209	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ENO2—brain cancer	1.22e-05	0.000206	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—BSG—brain cancer	1.19e-05	0.000202	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.18e-05	0.000199	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.14e-05	0.000193	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—ESR2—brain cancer	1.14e-05	0.000193	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ENO2—brain cancer	1.11e-05	0.000187	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BSG—brain cancer	1.1e-05	0.000185	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NOTCH2—brain cancer	1.08e-05	0.000183	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2C9—brain cancer	1.04e-05	0.000176	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—IDH1—brain cancer	1.03e-05	0.000174	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2C9—brain cancer	1.02e-05	0.000172	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—RELA—brain cancer	9.99e-06	0.000169	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—MYC—brain cancer	9.96e-06	0.000168	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—ERBB2—brain cancer	9.93e-06	0.000168	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2C9—brain cancer	9.6e-06	0.000162	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—IDH1—brain cancer	9.42e-06	0.000159	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SIRT1—brain cancer	9.19e-06	0.000155	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BSG—brain cancer	8.84e-06	0.000149	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2C9—brain cancer	8.8e-06	0.000149	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CTNNB1—brain cancer	8.69e-06	0.000147	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—BSG—brain cancer	8.64e-06	0.000146	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—BSG—brain cancer	8.16e-06	0.000138	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ENO2—brain cancer	8.12e-06	0.000137	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—brain cancer	8.03e-06	0.000136	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—brain cancer	7.65e-06	0.000129	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—IDH1—brain cancer	7.6e-06	0.000128	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—STAT3—brain cancer	7.57e-06	0.000128	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BSG—brain cancer	7.48e-06	0.000126	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—brain cancer	7.48e-06	0.000126	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ENO2—brain cancer	7.45e-06	0.000126	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—IDH1—brain cancer	7.43e-06	0.000125	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—brain cancer	7.35e-06	0.000124	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—brain cancer	7.2e-06	0.000122	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—IDH1—brain cancer	7.02e-06	0.000119	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—brain cancer	6.91e-06	0.000117	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—brain cancer	6.91e-06	0.000117	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—brain cancer	6.88e-06	0.000116	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—IDH1—brain cancer	6.43e-06	0.000109	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CG—brain cancer	6.41e-06	0.000108	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BSG—brain cancer	6.09e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ENO2—brain cancer	6.01e-06	0.000101	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ENO2—brain cancer	5.87e-06	9.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.71e-06	9.65e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CG—brain cancer	5.61e-06	9.47e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ENO2—brain cancer	5.55e-06	9.37e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.24e-06	8.85e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—IDH1—brain cancer	5.24e-06	8.85e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—brain cancer	5.09e-06	8.59e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO2—brain cancer	5.09e-06	8.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2C9—brain cancer	4.72e-06	7.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.26e-06	7.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO2—brain cancer	4.14e-06	6.99e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BSG—brain cancer	4.02e-06	6.78e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—brain cancer	3.73e-06	6.29e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—brain cancer	3.6e-06	6.08e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH1—brain cancer	3.45e-06	5.83e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—brain cancer	3.42e-06	5.77e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—brain cancer	2.76e-06	4.66e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO2—brain cancer	2.73e-06	4.61e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—brain cancer	2.69e-06	4.55e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—brain cancer	2.54e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—brain cancer	2.33e-06	3.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—brain cancer	1.9e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—brain cancer	1.25e-06	2.12e-05	CbGpPWpGaD
